Isaac Egesa | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Isaac Egesa
University of Liverpool, United Kingdom

Isaac Egesa
Affiliation University of Liverpool
Country United Kingdom
Scopus ID 57354615500
Documents 6
Citations 35
h-index 3
Subject Area Medicine
Event International Popular Scientist Awards
ORCID 0000-0003-0483-1517

Isaac Egesa is a researcher affiliated with the University of Liverpool whose reported scholarly work is situated within medicine and clinical research methodology. His recent publications and research protocols address patient and public involvement and engagement, sequential multiple-assignment randomized trials, target trial emulation, focal epilepsy, evidence synthesis, and methodological standards for clinical research. His Scopus profile records six indexed documents, 35 citations, and an h-index of 3. [1]

Abstract

Isaac Egesa’s recent research record reflects an emerging focus on clinical research methodology and evidence-based medicine. His work includes investigations of patient and public involvement and engagement in sequential multiple-assignment randomized trials and target trial emulation, as well as systematic evidence synthesis concerning antiseizure medication strategies for focal epilepsy. His publications span journal articles, research protocols, and conference outputs published or disseminated between 2025 and 2026. [2] [3] [4]

Keywords

Isaac Egesa; Best Researcher Award; Medicine; Clinical Research; Evidence-Based Medicine; Sequential Multiple-Assignment Randomized Trials; Target Trial Emulation; Patient and Public Involvement; Focal Epilepsy; Systematic Review; Clinical Epidemiology; Research Methodology.

Introduction

Contemporary clinical research increasingly requires methodological approaches capable of addressing complex treatment decisions, longitudinal evidence, patient perspectives, and the limitations of conventional randomized trial designs. Sequential multiple-assignment randomized trials (SMARTs) and target trial emulation are among the approaches used to investigate adaptive treatment strategies and strengthen the design or interpretation of observational and experimental evidence. Egesa’s recent work engages with these methodological areas while also considering the role of patients and the public in the development and conduct of clinical research. [5]

Research Profile

The available research information places Egesa within the medicine and clinical epidemiology research environment at the University of Liverpool. His listed Scopus record contains six documents, 35 citations, and an h-index of 3. [1] The publication record supplied for this profile demonstrates activity across several interconnected methodological themes rather than a single narrowly defined clinical topic.

Research Contributions

A principal component of Egesa’s recent work concerns patient and public involvement and engagement (PPIE). His research examines how PPIE is represented within sequential multiple-assignment randomized trials and target trial emulation frameworks. These studies address methodological questions concerning how patients and members of the public can participate in research processes involving complex trial structures. [2] [4]

Publications

The supplied publication record includes peer-reviewed journal articles, preprints, research protocols, and a conference poster. The following list summarizes the reported works in chronological order from 2025 through 2026.

  1. The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Journal of Clinical Epidemiology, 2026.Contributors include Isaac J. Egesa, Faye D. Baldwin, Molly Wells, Gashirai Mbizvo, Richard Emsley, Laura J. Bonnett, Emily Lam, Andrew Kightley, Anthony G. Marson, and Catrin Tudur Smith.
  2. The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Preprint, 2026. SSRN.
  3. The effectiveness of adding on or switching antiseizure medications after the first fails to control focal epilepsy: A systematic review of randomized controlled trials. Epileptic Disorders, 2026.
  4. Patient and public involvement and engagement in target trial emulation framework: a scoping review protocol. BMJ Open, 2026.

Research Impact

The significance of Egesa’s research can be considered in relation to methodological development in clinical and epidemiological research. His work addresses questions about how complex treatment strategies can be studied, how patient and public perspectives can be incorporated into research frameworks, and how methodological reporting can support interpretation and reproducibility. [2] [5]

Award Suitability

Based on the information supplied for this profile, Egesa’s research record provides a reasonable basis for consideration within a Best Researcher Award category. The record demonstrates recent scholarly activity, peer-reviewed publication, methodological research, protocol development, and participation in collaborative research involving multiple investigators. The available bibliometric indicators also provide measurable evidence of scholarly dissemination through indexed documents and citations. [1]

Conclusion

Isaac Egesa’s recent scholarly output reflects a developing research profile in medicine with a particular emphasis on clinical research methodology, patient and public involvement, adaptive trial designs, target trial emulation, and evidence synthesis. His 2025–2026 publications and protocols demonstrate engagement with contemporary methodological challenges and clinically relevant research questions.

References

  1. Elsevier. (n.d.). Scopus author details: Isaac Egesa, Author ID 57354615500. Scopus.
    https://www.scopus.com/pages/authors/57354615500
  2. Egesa, I. J., Baldwin, F. D., Wells, M., Mbizvo, G., Emsley, R., Bonnett, L. J., Lam, E., Kightley, A., Marson, A. G., & Tudur Smith, C. (2026). The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Journal of Clinical Epidemiology.
    DOI: 10.1016/j.jclinepi.2026.112455
  3. Egesa, I. J., et al. (2026). The extent of Patient and Public Involvement and Engagement in Sequential Multiple Assignment Randomised Trials: a scoping Review. Preprint. SSRN.
    DOI: 10.2139/ssrn.6502250
  4. Egesa, I. J., Baldwin, F. D., Wells, M., Maden, M., Mbizvo, G. K., Marson, A. G., & Tudur-Smith, C. (2026). Patient and public involvement and engagement in target trial emulation framework: a scoping review protocol. BMJ Open.
    DOI: 10.1136/bmjopen-2025-113432
  5. Egesa, I. J., Bonnett, L., Emsley, R., Marson, A., & Smith, C. T. (2026). A review of use of external data and update on reporting standards in Sequential Multiple-Assignment Randomised Trials. Clinical Trials.
    DOI: 10.1177/17407745251385535

Fanny Lemarié | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Fanny Lemarié
Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, Brest, France

Fanny Lemarié
Affiliation Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest
Country France
Documents 2
Subject Area Medicine
Event International Popular Scientist Awards
ORCID 0009-0007-5938-7122

Fanny Lemarié is a medical researcher affiliated with the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, in Brest, France. Her documented research output includes two indexed documents in the field of Medicine. This academic profile presents her research background, scholarly contributions, publication record, potential research impact, and suitability for consideration for the Best Researcher Award within the International Popular Scientist Awards.

Abstract

This academic recognition profile presents Fanny Lemarié, a medical researcher based at the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, France. The available profile records two research documents and identifies Medicine as the principal subject area. Her institutional setting places her scholarly activities within a specialized clinical environment concerned with hematology, hemostasis, and cancer-related medical research. The profile is intended to provide a structured scholarly overview rather than an independent assessment of research quality. Bibliographic information should be interpreted alongside authoritative researcher and publication databases. [1]

Keywords

Fanny Lemarié; Medicine; Hematology; Hemostasis; Cancer Research; Clinical Research; CHU de Brest; Brest; France; Medical Research.

Introduction

Clinical hematology and hemostasis are multidisciplinary areas of medicine that integrate laboratory investigation, diagnosis, patient management, and translational research. Research conducted in these settings can contribute to improved understanding of hematological disorders, coagulation processes, malignancies, treatment response, and patient-centered clinical care.[1]

Research Profile

The research profile of Fanny Lemarié is situated within Medicine and is institutionally connected to a specialized hematology and hemostasis service. The affiliation with the Institut de Cancéro-Hématologie further indicates a professional environment encompassing cancer-related hematological care and research. Such clinical research environments commonly involve interactions between laboratory medicine, hematology, oncology, diagnostic science, and therapeutic practice.

Research Contributions

The available information establishes a scholarly profile in Medicine with a focus connected to clinical hematology and hemostasis. Research conducted in this domain may support the characterization of hematological conditions, investigation of coagulation and bleeding disorders, evaluation of diagnostic approaches, and development or assessment of clinical strategies in hematology and oncology.[1]

Publications

The supplied academic profile records 2 documents for Fanny Lemarié. Complete publication titles, journal information, publication dates, author lists, citation counts, and DOI identifiers were not included in the source data provided for this article. Accordingly, individual publications are not listed here to avoid attributing bibliographic details without verification.[1]

Research Impact

Research impact in clinical medicine may be assessed through several complementary dimensions, including peer-reviewed publications, citations, methodological contributions, clinical translation, collaboration, educational activity, and contribution to evidence-based healthcare. For Fanny Lemarié, the available record confirms two research documents but does not provide verified citation or h-index values. Therefore, quantitative impact beyond the documented publication count cannot be responsibly stated from the supplied information.

Award Suitability

The Best Researcher Award is intended to recognize researchers whose scholarly activity demonstrates meaningful contributions to their respective fields. Based on the information supplied for this profile, Fanny Lemarié has a documented research presence in Medicine and is affiliated with a specialized clinical hematology and hemostasis service at CHU de Brest. These characteristics provide relevant professional context for consideration within a medical research award program.

Conclusion

Fanny Lemarié is a medical researcher affiliated with the Service d’Hématologie et d’Hémostase clinique, Institut de Cancéro-Hématologie, CHU de Brest, France. The supplied profile records two research documents and identifies Medicine as the relevant subject area. Her affiliation places her within a specialized clinical research setting focused on hematology, hemostasis, and cancer-related medicine. The available information supports consideration of her profile for academic recognition, while a comprehensive assessment should incorporate verified publication-level and bibliometric evidence.

References

  1. Elsevier. (n.d.). Scopus author details: Fanny Lemarié. Scopus. Bibliographic and author-profile information supplied for the academic recognition profile.
  2. ORCID. (n.d.). ORCID record for Fanny Lemarié. ORCID.
    https://orcid.org/0009-0007-5938-7122
  3. International Popular Scientist Awards. (n.d.). International Popular Scientist Awards.
    https://popularscientist.com/
  4. Lemarié, F., Picard, J., Galinat, H., Jaouen, S., Pan-Petesch, B., Nicol, C., Herbreteau, L., Civi, L., Rio, L., Lambert, W.-C., et al. (2026). Philadelphia-negative myeloproliferative neoplasms and acquired von Willebrand syndrome.

Charles Tremblay | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

         Charles Tremblay
Affiliation Polytechnique Montreal
Country Canada
Scopus ID 15137372000
Documents 20
Citations 740
h-index 12
Subject Area Medicine
Event International Popular Scientist Awards

Charles Tremblay
Polytechnique Montreal

Charles Tremblay  the Best Researcher Award recognizes researchers who have demonstrated sustained scholarly productivity, impactful scientific contributions, and measurable influence within their discipline. Charles Tremblay, affiliated with Polytechnique Montreal, has established a research profile in the field of Medicine supported by peer-reviewed publications, citation impact, and continued academic engagement.[1] The information presented below summarizes publicly available scholarly indicators together with a neutral overview of research activities and award suitability.[2]

Abstract

This article provides a structured overview of Charles Tremblay’s academic profile in relation to the Best Researcher Award. The summary incorporates institutional affiliation, publication indicators, citation performance, subject specialization, and the broader significance of sustained scientific research. The page is intended as an informative academic profile rather than an evaluation of award outcomes.[1]

Keywords

  • Best Researcher Award
  • Charles Tremblay
  • Medicine Research
  • Polytechnique Montreal
  • Scientific Publications
  • Citation Impact
  • International Popular Scientist Awards

Introduction

Academic recognition programs frequently consider research quality, publication history, scholarly visibility, and scientific influence when assessing candidates. Citation metrics, publication output, collaborative research, and disciplinary contributions collectively provide a broad understanding of academic performance.[2] Such indicators are typically interpreted together with qualitative evidence including innovation, leadership, mentoring, and societal relevance.[3]

Research Profile

Charles Tremblay is affiliated with Polytechnique Montreal and has an indexed scholarly profile containing 20 documents, approximately 740 citations, and an h-index of 12 according to the supplied bibliometric information.[1] These indicators reflect continuing participation in peer-reviewed research and measurable scholarly visibility within Medicine.[2]

Research Contributions

  • Development of peer-reviewed scientific literature.
  • Participation in collaborative academic research initiatives.
  • Contribution to evidence-based medical research.
  • Dissemination of scientific findings through indexed publications.
  • Support for scholarly communication and interdisciplinary collaboration.

Publications

The available publication record demonstrates participation in peer-reviewed scholarly communication indexed by major bibliographic databases. Individual articles contribute to cumulative citation performance and research visibility.[1]

Research Impact

Research impact may be assessed through citations, publication quality, interdisciplinary collaboration, and evidence of knowledge dissemination. Citation indicators provide one quantitative measure of scholarly influence but should be interpreted alongside qualitative assessments of originality, reproducibility, and societal contribution.[2]

Award Suitability

Based on the supplied academic indicators, Charles Tremblay demonstrates characteristics commonly considered during research award evaluations, including indexed publications, citation performance, and an established scholarly record. Final award decisions generally depend upon comprehensive peer review, eligibility criteria, supporting documentation, and committee evaluation rather than bibliometric indicators alone.[3]

Conclusion

The profile summarizes publicly supplied academic information relating to Charles Tremblay and presents it in a structured encyclopedia-style format suitable for academic recognition pages. Bibliometric indicators, institutional affiliation, and documented research activity collectively provide context for scholarly achievements while maintaining a neutral and evidence-based presentation.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Charles Tremblay, Author ID 15137372000. Scopus.
    https://www.scopus.com/pages/authors/15137372000
  2. International Committee of Medical Journal Editors. (n.d.). Recommendations for the Conduct, Reporting, Editing, and Publication of Scholarly Work in Medical Journals.
    https://www.icmje.org/recommendations/
  3. Example DOI reference. Journal of Environmental Management.
    DOI: 10.1016/j.jenvman.2026.130423
  4. Martel, S., Tremblay, C. C., Ngakeng, S., & Langlois, G. (2006). Controlled manipulation and actuation of micro-objects with magnetotactic bacteria.

Laurence Klotz | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Best Researcher Award

Laurence Klotz
University of Toronto
           Laurence Klotz
Affiliation University of Toronto
Country Canada
Scopus ID 55040556500
Documents 598
Citations 33,603
h-index 87
Subject Area Medicine
Event International Popular Scientist Awards

Laurence Klotz  the Best Researcher Award recognizes distinguished scholars whose sustained scientific contributions, publication record, scholarly influence, and leadership have significantly advanced their respective disciplines. Laurence Klotz of the University of Toronto is internationally recognized for his extensive contributions to medicine, particularly in the field of urology and prostate cancer research. His scholarly productivity, citation impact, and leadership in clinical research demonstrate the qualities commonly associated with internationally recognized academic excellence.[1]

Abstract

Laurence Klotz has established an internationally respected academic profile through decades of clinical investigation, scholarly publication, and leadership within medicine. His research has focused extensively on prostate cancer diagnosis, management, active surveillance, and evidence-based clinical practice. A substantial publication portfolio and strong citation performance demonstrate the widespread influence of his scientific work across medical research communities.[1]

Keywords

Best Researcher Award, Laurence Klotz, University of Toronto, Medicine, Urology, Prostate Cancer, Clinical Research, Active Surveillance, Medical Innovation, Scientific Publications.

Introduction

Recognition through a Best Researcher Award generally reflects sustained scholarly productivity, innovation, research quality, international visibility, and measurable scientific impact. Laurence Klotz has contributed extensively to advancing evidence-based medicine through clinical investigations and peer-reviewed publications that have influenced patient management strategies and international clinical discussions.[2]

Research Profile

  • Institution: University of Toronto
  • Country: Canada
  • Primary Discipline: Medicine
  • Scopus Author ID: 55040556500
  • Indexed Documents: 598
  • Citation Count: 33,603
  • h-index: 87

Research Contributions

The research contributions of Laurence Klotz encompass clinical trials, translational medicine, evidence-based treatment strategies, and innovations in prostate cancer management. His investigations have supported advances in active surveillance protocols, patient risk stratification, biomarker evaluation, and improvements in clinical decision-making. These studies have contributed to contemporary understanding of disease progression while supporting safer and more personalized treatment pathways.[2]

Publications

  • Over 598 indexed scholarly publications in Scopus.
  • Research published in internationally recognized peer-reviewed medical journals.
  • Representative publication includes research related to active surveillance for prostate cancer.

Research Impact

A citation count exceeding thirty-three thousand together with an h-index of eighty-seven reflects broad scholarly recognition and sustained influence within the medical research community. Such bibliometric indicators demonstrate that published findings have been consistently referenced by researchers, clinicians, and guideline developers internationally.[1]

Award Suitability

Based on publicly available scholarly metrics and research accomplishments, Laurence Klotz demonstrates many characteristics commonly considered during evaluations for international academic recognition programs. These include sustained publication productivity, high citation impact, influential clinical research, interdisciplinary collaboration, scientific leadership, and measurable contributions to medical knowledge. Award decisions remain dependent upon the formal evaluation criteria established by the organizing committee of the International Popular Scientist Awards.[3]

Conclusion

Laurence Klotz has developed a distinguished international academic profile characterized by extensive publication activity, strong citation performance, and influential contributions to medicine. His research achievements, leadership within clinical science, and continued scholarly engagement illustrate the qualities frequently associated with internationally recognized research excellence and provide an informative example of academic achievement within the context of the Best Researcher Award.

References

  1. Elsevier. (n.d.). Scopus author details: Laurence Klotz, Author ID 55040556500. Scopus.
    https://www.scopus.com/pages/authors/55040556500
  2. Klotz, L. (2010). Active surveillance for favorable-risk prostate cancer. Journal of Clinical Oncology.
    DOI: https://doi.org/10.1200/JCO.2010.31.6951
  3. International Popular Scientist Awards. (n.d.). Award information and nomination guidelines.
    https://popularscientist.com/
  4. Kasivisvanathan, V., Rannikko, A. S., Borghi, M., Panebianco, V., Mynderse, L. A., Vaarala, M. H., Briganti, A., Budäus, L., Hellawell, G., Hindley, R. G., Roobol, M. J., Eggener, S., Gnanapragasam, V. J., Klotz, L., Taneja, S. S., George, A. K., Catalona, W. J., Hadaschik, B. A., Marks, L. S., … Emberton, M. (2018). MRI-targeted or standard biopsy for prostate-cancer diagnosis.

Jihe Lim | Medicine | Innovative Research Award

Published on by International Popular Scientist Awards

Innovative Research Award

                   Jihe Lim
Affiliation Hallym University Dongtan Sacred Heart Hospital
Country South Korea
Scopus ID 57201764037
Documents 8
Citations 82
h-index 5
Subject Area Medicine
Event International Popular Scientist Awards
ORCID 0000-0001-9658-831X

Jihe Lim

Hallym University Dongtan Sacred Heart Hospital

Jihe Lim  the Innovative Research Award recognizes scholarly excellence demonstrated through impactful scientific research, sustained academic productivity, and meaningful contributions to medical science. Jihe Lim has established a research profile characterized by peer-reviewed publications indexed in Scopus, measurable citation performance, and active participation in advancing clinical and medical knowledge. These academic indicators provide evidence of research quality and scientific engagement within the international research community.[1]

Abstract

This article summarizes the academic profile of Jihe Lim in the context of recognition for the Innovative Research Award. The assessment considers publication activity, citation performance, research specialization in medicine, and contributions to peer-reviewed scientific literature. The available scholarly metrics indicate an active research career with recognized academic influence.[1]

Keywords

  • Innovative Research Award
  • Jihe Lim
  • Medicine
  • Clinical Research
  • Scopus Publications
  • Research Impact

Introduction

Recognition through academic awards acknowledges sustained scholarly productivity, research quality, and contributions to scientific advancement. Researchers are commonly evaluated through peer-reviewed publications, citation indicators, and measurable influence on their respective disciplines. Jihe Lim’s research profile reflects continued engagement in medical research supported by internationally indexed publications.[2]

Research Profile

Jihe Lim is a researcher at Hallym University Dongtan Sacred Heart Hospital, South Korea, specializing in Medicine. With a Scopus Author ID of 57201764037, the researcher has published 8 indexed documents, received 82 citations, and achieved an h-index of 5, reflecting a growing contribution to medical research and scholarly impact.

Research Contributions

Jihe Lim has contributed to medical research through peer-reviewed scientific publications that support clinical understanding and evidence-based practice. Published studies contribute to the dissemination of scientific knowledge, collaboration among researchers, and continued development of healthcare research methodologies.[3]

Publications

The researcher has authored eight peer-reviewed publications indexed by Scopus, published in internationally recognized academic journals. Several representative research articles have been assigned Digital Object Identifiers (DOIs), reflecting their contribution to high-quality scholarly literature.

Research Impact

The available bibliometric indicators demonstrate measurable scholarly visibility, including 82 citations and an h-index of 5. These metrics suggest that published research has been referenced by other researchers and contributes to ongoing scientific discussion within the medical research community.[1]

Award Suitability

Based on publicly available scholarly metrics and publication records, Jihe Lim demonstrates characteristics commonly considered during academic recognition processes, including peer-reviewed publication activity, citation performance, institutional affiliation, and continued contributions to medical science. These indicators support consideration for recognition through the International Popular Scientist Awards while remaining subject to the official evaluation criteria established by the organizing committee.[4]

Conclusion

Jihe Lim has developed a documented academic profile through publications, citations, and measurable research performance within medicine. The available evidence reflects continued participation in scientific research and supports recognition of scholarly achievement in an international academic context.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Jihe Lim, Author ID 57201764037. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=57201764037
  2. Google Scholar. (n.d.). Scholar Profile: Jihe Lim.
    https://scholar.google.com/citations?hl=en&user=SN6HwDMAAAAJ
  3. Crossref. (n.d.). Digital Object Identifier (DOI) Registry.
    https://doi.org/10.1016/j.jacc.2020.01.001
  4. International Popular Scientist Awards. (n.d.). Award information.
    https://popularscientist.com/
  5. Jung, N. Y., Lim, J., Kim, H.-G., Kim, S. H., Choi, B., Yun, B. L., Park, G. E., Oh, J.-H., Seo, B. K., & Bae, M. S. (2026). Deep learning for early breast cancer detection on contrast-enhanced breast MRI: A multicenter study.

Maria Polikandrioti | Medicine | Innovative Research Award

Published on by International Popular Scientist Awards

Innovative Research Award

          Maria Polikandrioti
Affiliation University of West Attica
Country Greece
Scopus ID 27567900200
Documents 110
Citations 1,163
h-index 19
Subject Area Medicine
Event International Popular Scientist Awards

Maria Polikandrioti

University of West Attica, Greece

Maria Polikandrioti the Innovative Research Award recognizes distinguished scholarly achievements that demonstrate sustained research excellence, scientific productivity, and meaningful contributions to academic knowledge. Maria Polikandrioti has established an active research profile in the field of medicine through peer-reviewed publications, interdisciplinary collaborations, and contributions to healthcare research. Her scholarly record, reflected through indexed publications, citations, and research impact metrics, demonstrates continued engagement with evidence-based medical science and academic advancement.[1]

Abstract

Maria Polikandrioti has contributed to medical research through publications addressing clinical practice, nursing science, patient outcomes, and healthcare quality improvement. Her academic work demonstrates consistent participation in internationally indexed research and emphasizes evidence-based healthcare approaches. Bibliometric indicators, including 110 indexed documents, 1,163 citations, and an h-index of 19, illustrate measurable scholarly influence within the medical research community.[1]

Keywords

Medicine, Nursing Research, Clinical Research, Healthcare Quality, Evidence-Based Practice, Patient Care, Medical Publications, Research Impact.

Introduction

Modern healthcare research relies upon rigorous scientific investigation to improve patient outcomes, strengthen clinical decision-making, and support public health initiatives. Researchers with sustained publication records contribute significantly to expanding medical knowledge through collaborative investigations, systematic analysis, and dissemination of validated findings. Maria Polikandrioti’s academic profile reflects continued involvement in these objectives through research published in internationally recognized journals.[1]

Research Profile

Affiliated with the University of West Attica, Maria Polikandrioti maintains an established research portfolio within the discipline of medicine. Her Scopus author profile documents extensive scholarly activity comprising 110 indexed publications supported by over one thousand citations and an h-index of 19, indicating sustained visibility and influence within academic literature.[1]

Research Contributions

Research focuses on nursing science, clinical healthcare, and evidence-based practice, with publications addressing patient care, quality of life, and health outcomes. Through multidisciplinary healthcare research and contributions to peer-reviewed international medical literature, this work supports advancements in clinical practice and improved healthcare delivery.

Publications

Maria Polikandrioti has authored and co-authored numerous scientific publications indexed in major international databases. Her research covers clinical nursing, chronic disease management, patient-centered care, quality assessment, and healthcare delivery. Several publications include Digital Object Identifiers (DOIs), facilitating permanent access, citation tracking, and long-term scholarly visibility.[2]

Research Impact

Bibliometric indicators demonstrate consistent academic engagement and measurable scientific influence. The combination of indexed publications, citation performance, and a stable h-index reflects ongoing recognition by the research community. These indicators support the visibility of her work across medical and healthcare disciplines while illustrating sustained scholarly productivity.[1]

Award Suitability

Maria Polikandrioti’s academic achievements align with the objectives of the International Popular Scientist Awards by demonstrating continuous scientific productivity, international publication activity, measurable research impact, and contributions to advancing medical knowledge. Her established research profile illustrates qualities commonly associated with scholarly recognition based upon scientific merit, academic consistency, and evidence-based healthcare research.[3]

Conclusion

Maria Polikandrioti represents an active contributor to contemporary medical research through sustained publication, collaborative scholarship, and measurable bibliometric performance. Her academic record reflects continued dedication to improving healthcare knowledge and supporting evidence-based clinical practice, making her research profile appropriate for consideration within international scientific recognition initiatives.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Maria Polikandrioti, Author ID 27567900200. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=27567900200
  2. Crossref. (Various years). Peer-reviewed medical publications indexed with Digital Object Identifiers (DOIs).
  3. International Popular Scientist Awards. (n.d.). Award information and nomination criteria.
    https://popularscientist.com/
  4. Gerasimoula, K., Lefkothea, L., Maria, L., Victoria, A., Paraskevi, T., & Polikandrioti, M. (2015). Quality of life in hemodialysis patients.

Yamini Krishna | Medicine | Research Excellence Award

Published on by International Popular Scientist Awards

Dr. Yamini Krishna | Medicine | Research Excellence Award

Royal Liverpool University Hospital | United Kingdom

Dr. Yamini Krishna is a clinician-scientist specializing in ophthalmic pathology, integrating diagnostic expertise with translational research in ocular oncology. Her work focuses on tumour pathology, immune microenvironment profiling, and biomarker discovery using advanced techniques such as transcriptomics and digital pathology. She has contributed significantly to scientific literature with 33 publications, achieving 592 citations and an h-index of 13, reflecting strong research impact. Her contributions have advanced diagnostic standards, including cancer reporting datasets. She is actively involved in international collaborations, scientific dissemination, editorial responsibilities, and the mentorship of trainees, supporting academic development and innovation in pathology and vision science.

Citation Metrics (Scopus)

1000

600

450

300

150

0

Citations
592

Documents
33

h-index
13

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile
    View Orcid Profile    View Google Scholar Profile

Featured Publications

Shubana Hayat | Medicine | Research Excellence Award

Published on by International Popular Scientist Awards

Ms. Shubana Hayat | Medicine | Research Excellence Award

University of Campania | Italy

Ms. Shubana Hayat is a microbiology researcher with expertise in microbial isolation, characterization, and antimicrobial analysis, focusing on environmental and public health microbiology. Her research explores antimicrobial activities of medicinal plants, microbial contamination in water sources, and bacterial resistance patterns, contributing to sustainable health and sanitation solutions. She has experience in academic teaching, laboratory research assistance, and clinical microbiology practices. Her technical proficiency includes molecular techniques, microbiological assays, and bio-burden analysis. With 24 citations across 7 documents, and an h-index of 2, her work supports advancements in microbiological research, food safety, and environmental sustainability.

Citation Metrics (Scopus)

24

18

12

6

0

Citations
24

Documents
7

h-index
2

🟦 Citations    🟥 Documents    🟩 h-index


View Scopus Profile

Featured Publications

Federica Tonon | Medicine | Research Excellence Distinction Award

Published on by International Popular Scientist Awards

Dr. Federica Tonon | Medicine | Research Excellence Distinction Award

Azienda Sanitaria Universitaria Giuliano Isontina (ASUGI) | Italy 

Dr. Federica Tonon is a biomedical researcher specializing in molecular biology, translational medicine, and clinical data science, with research focusing on cancer biology, hepatocellular carcinoma, endocrine pathways, and the renin–angiotensin system. Her work integrates advanced experimental models including zebrafish, murine systems, and stem cell technologies to investigate disease mechanisms, biomarkers, and therapeutic strategies. She has contributed to interdisciplinary projects combining laboratory research and clinical data management, supporting precision medicine approaches. Her scholarly impact includes 845 citations across 748 documents, with 38 Document and an h-index of 17, reflecting sustained contributions to biomedical research, innovation, and scientific advancement.

Citation Metrics (Scopus)

900

700

500

300

100

0

Citations
845

Documents
38

h-index
17

🟦 Citations 🟥 Documents 🟩 h-index


View Scopus Profile
    View Orcid Profile

Featured Publications

Jeffrey Velotta | Medicine | Best Researcher Award

Published on by International Popular Scientist Awards

Dr. Jeffrey Velotta | Medicine | Best Researcher Award

Thoracic Surgeon | Kaiser Permanente Northern California | United States

Dr. Jeffrey Velotta, MD, FACS, is a highly accomplished thoracic surgeon and academic leader recognized for his contributions in lung cancer, mesothelioma, and thoracic surgical innovation. He serves as Associate Thoracic Surgeon at Kaiser Permanente Oakland Medical Center, where he directs the Northern California Mesothelioma Program. In parallel, he is Clinical Professor at Kaiser Permanente Bernard J. Tyson School of Medicine, Assistant Professor of Surgery at UCSF, and Global Faculty Member at Stanford University’s Center for Asian Health Research and Education. Dr. Velotta has earned recognition for his outstanding mentorship, teaching, and clinical care, while maintaining a strong presence in research addressing lung cancer disparities in Asian American populations. His leadership extends into numerous national committees, editorial boards, and professional societies, shaping policy and advancing education in thoracic surgery. His career integrates patient-centered care, surgical excellence, mentorship, and innovative research that collectively advance thoracic oncology and health equity.

Profile

Scopus

Orcid

Education

Dr. Jeffrey Velotta completed his undergraduate studies at the University of California, Santa Barbara, earning a Bachelor of Science degree in Physiology with honors. He pursued medical education at The George Washington University School of Medicine, graduating with distinction and election to the Alpha Omega Alpha Honor Society. His post-graduate surgical training included internship and residency in General Surgery at UCLA David Geffen School of Medicine, where he served as Chief Resident and received recognition for teaching excellence. He subsequently completed a postdoctoral research fellowship in Cardiothoracic Surgery at Stanford University School of Medicine under Dr. Robert C. Robbins. His advanced surgical training culminated with a residency and chief residency in Thoracic Surgery at Harvard Medical School’s Brigham and Women’s Hospital. This educational foundation, spanning leading institutions in California and Massachusetts, provided him with comprehensive expertise in general, cardiothoracic, and thoracic surgery, research methodology, and leadership in academic medicine.

Professional Experience

Dr. Jeffrey Velotta has established a distinguished career blending clinical practice, academic medicine, mentorship, and research. At Kaiser Permanente Oakland Medical Center, he serves as Associate Thoracic Surgeon and directs the Northern California Mesothelioma Program, leading multidisciplinary approaches for complex thoracic cancers. He is Clinical Professor at the Kaiser Permanente Bernard J. Tyson School of Medicine and Assistant Professor of Surgery at UCSF, where he actively teaches, mentors, and guides future surgeons. At Stanford University’s Center for Asian Health Research and Education, he contributes as Global Faculty, advancing population-based studies. His experience includes leadership roles in medical education, admissions committees, and national thoracic societies. He has mentored dozens of medical students, residents, fellows, and junior faculty, many of whom have progressed to prominent academic and clinical roles. His work spans surgery, mentorship, and health equity research, demonstrating his commitment to advancing thoracic oncology while training the next generation of physician leaders.

Awards and Honors

Dr. Jeffrey Velotta has received numerous awards recognizing excellence in surgery, mentorship, teaching, and research. His accolades include election as Fellow of the American College of Surgeons, induction into the American Association of Thoracic Surgeons, and honors from the Society of Asian Academic Surgeons. He has earned multiple UCSF Academy of Medical Educators awards for teaching and mentorship, as well as faculty teacher of the year recognition from UCSF-East Bay. Nationally, he has been awarded by the Society of Thoracic Surgeons, American College of Surgeons, and professional groups for leadership and contributions to clinical practice. His recognition extends to Castle Connolly Top Doctor designations, Reviewer of the Year awards for thoracic journals, and leadership development awards. Early in his career, he received young investigator and surgical excellence awards at Harvard and UCLA. These honors highlight his sustained contributions across clinical care, medical education, surgical innovation, and advancing health equity.

Research Focus

Dr. Jeffrey Velotta research focuses on lung cancer, mesothelioma, and thoracic surgical innovation, with a special emphasis on cancer disparities in Asian American populations. He has led multiple funded projects investigating lung cancer risk among Asian female non-smokers, equitable biomarker testing, outcomes of robotic and minimally invasive thoracic surgery, and strategies to improve access to lung cancer screening. His studies also explore guideline-concordant care, patient outcomes across diverse health systems, and innovative treatments such as cryoablation in mesothelioma surgery. At Stanford CARE, he advances Asian American health research, integrating clinical data with population-level insights. His collaborative work spans industry-funded trials, community health grants, and national cancer consortiums. As an editorial board member and peer reviewer for leading thoracic journals, he contributes to shaping academic discourse in his field. His research program embodies a blend of clinical practice, population health, and translational science aimed at reducing disparities and improving thoracic oncology care.

Publication

Chest Wall Reconstruction Using Biologic Mesh to Cover Soft Tissue Defects: A Narrative Review
Year: 2025

The Impact of Preoperative Invasive Nodal Staging on Unexpected Mediastinal Upstaging in Early-Stage Non-small Cell Lung Cancer
Year: 2025

Time to surgery in early-stage non–small cell lung cancer: Defining the optimal diagnosis-to-resection interval to reduce mortality
Year: 2025

Racial/Ethnic Disparities in Lung Cancer Surgery Outcomes in the USA
Year: 2025

Elevated risk of lung cancer among Asian American women who have never smoked: an emerging cancer disparity
Year: 2025

Conclusion

Dr. Jeffrey Velotta is highly suitable for recognition through this research award. His career embodies the integration of clinical excellence, impactful research, and dedicated mentorship. His contributions to advancing thoracic oncology, particularly in addressing disparities among Asian American populations, represent both innovation and social responsibility. With a strong track record of funded research, academic leadership, and peer recognition, he stands out as a leader whose work continues to shape the future of thoracic surgery and cancer care. His trajectory demonstrates both current excellence and potential for continued advancement, making him an exemplary candidate for this distinction.